As the leading Tdap vaccine in the United States with more than 67 million doses supplied, Adacel vaccine provides extensive real-world, clinical experience for adult and adolescent pertussis vaccination in the United States.1


Experts estimate that up to 3.3 million adult and adolescent cases of pertussis occur every year in the United States.2







